Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-16-002732
Filing Date
2016-02-03
Accepted
2016-02-02 20:02:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 NORTHPOINTE CAPITAL LLC iccca1_20216.htm SC 13G/A 25848
  Complete submission text file 0001085146-16-002732.txt   27336
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Subject) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39373 | Film No.: 161382766
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 39400 WOODWARD AVE SUITE 190 BLOOMFIELD HILLS MI 48304
Business Address 39400 WOODWARD AVE SUITE 190 BLOOMFIELD HILLS MI 48304 248-457-1559
NORTHPOINTE CAPITAL LLC (Filed by) CIK: 0001132668 (see all company filings)

EIN.: 233025935 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A